ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches

2Firsts Events by 2FIRSTS, edited by Sophia
Sep.20.2024
ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
At InterTabac, Pablo, the legal analysis director from ECigIntelligence, stated in a conversation with 2Firsts that the global trend towards reducing tobacco harm reduction is strengthening, leading to increasingly strict regulation of NGPs. He pointed out that brands need to be prepared to face this pressure, especially in the field of nicotine pouches.

On September 19th, the InterTabac officially opened in Germany. As the official media partner, 2Firsts arrived at the event and had a discussion with Pablo Cano Trilla, the Head of Legal Analysis from ECigIntelligence.

 

TobaccoIntelligence is a professional tobacco consulting company based in Spain, with a sister company focused on the e-cigarette industry called ECigIntelligence. Both are independent brands operated by the same parent company, Tamarind Intelligence. At the industry conference during this expo, Pablo represented ECigIntelligence and delivered a speech titled "Legal Challenges, Prospects and Future Projections in the Evolving Nicotine and Novel Tobacco Sectors."

 

After the speech, Pablo discussed with 2Firsts that globally, there is a growing trend of reducing harm from tobacco, leading to increasingly strict regulations on new tobacco products. He pointed out that brands need to be prepared to face this pressure, especially in the area of nicotine pouches. 

 

He emphasized that the most likely scenario is that nicotine pouches are not going to be banned, but this is not something that should be discarded.

 

ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
Pablo speaks at a lecture | Image source: 2Firsts

 

NGPs face strict regulation, nicotine pouches may be banned

 

As the head of legal analysis at a professional tobacco consulting company, Pablo states that 2024 will be a crucial turning point for EU regulation of new tobacco products, particularly in the regulation of emerging products such as nicotine pouches. Pablo anticipates that the revised Tobacco Products Directive (TPD) will introduce more uniform rules, covering pre-market approval, advertising restrictions, and environmental regulations for products like nicotine pouches.

 

He emphasized that nicotine pouches have become a new target for regulation. Whether they will be banned or not remains uncertain. Nicotine pouch manufacturers and sellers need to closely monitor policy changes to ensure their products meet new regulatory requirements and adapt to the constantly evolving market environment.

 

Furthermore, Pablo told 2Firsts that European policymakers are paying particular attention to the regulation of e-vapor products (EVP), with a decreasing demand for disposable e-cigarettes in the European market (especially in the UK, Germany, and France) and a shift towards refillable products becoming the new mainstream. He mentioned that policies such as flavor bans for disposable products not only affect the European market but may also have a ripple effect on other regions, such as Brazil in Latin America.

 

ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
Pablo's speech content │ Image source: 2Firsts

 

Taste preferences for nicotine pouches vary between Europe and US, with potential in the Latin America

 

Pablo mentioned to 2Firsts that there are certain differences between the European and American markets in terms of nicotine pouch flavor preferences.

 

For example, in the fourth quarter of 2023, he pointed out that consumers in Europe and America both prefer nicotine pouch products with a cool sensation flavor.

 

In Europe, consumers have a greater preference for nicotine pouches in "fruit" and "mixed" flavors. In the fourth quarter of 2023, the market share of "fruit" nicotine pouches reached 27%, while "mixed" flavors reached 24%.

 

In the emerging e-cigarette market, Pablo believes that Latin America has tremendous market potential. Despite Southeast Asia being a hot spot in the industry, increasingly strict regulations have made its market prospects less clear. Additionally, the launch of proprietary brand products by China Tobacco (CNTC) at the trade show demonstrates China's significant position in the global tobacco industry, warranting industry attention.

 

ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
Pablo's speech content │ Image source: 2Firsts

 

Prediction: HTP, EVP, and OND facing different opportunities

 

Pablo predicts that HNB tobacco products (HTP), e-cigarette vapor products (EVP), and nicotine pouches (OND) will face different growth opportunities in 2025.

 

He believes that HNB products will experience rapid growth, especially in markets such as the Middle East and North America, as well as in European countries such as Italy, and Spain.

 

According to forecasts from Pablo, e-cigarette vapor products have huge market potential in Latin America. Nicotine pouches have become very popular in European and American markets, especially the brand represented by ZYN has achieved significant success in the US market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
The UK Department of Health and Social Care published new guidance on Aug. 11 outlining the next phase of retail rules under the Tobacco and Vapes Act 2026, which will take effect on Oct. 29, 2026. The measures extend the minimum age of sale of 18 to all vaping and consumer nicotine products and restrict proxy purchasing, promotional giveaways and substantial discounts. Relevant offences in England, Wales and Scotland may carry a £200 fixed penalty notice, while persistent offenders can face temporary sales bans.
Aug.12
Product | BAT Expands VELO Travellers’ Collection With Mexico, Spain and Sweden Summer Edition Nicotine Pouches
Product | BAT Expands VELO Travellers’ Collection With Mexico, Spain and Sweden Summer Edition Nicotine Pouches
British American Tobacco (BAT) Global Travel Retail has expanded the VELO Travellers’ Collection with three new Summer Editions: Mexico, Spain and Sweden. Inspired by destination themes, the new nicotine pouch variants are designed for global travel-retail channels. The launch further strengthens VELO’s positioning as a travel-retail exclusive product collection.
Aug.27
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14